Bioterrorism

Publication Date	July 2009
Publisher	Global Industry Analysts
Product Type	Report
Pages	273
ISBN Number	not applicable
Product Code	GIA01302

Buy this product or for assistance call +44 20 7060 7474

PDF £2,375.00$3951 | €2658

FAX Order above formats by FAX

Summary

This report analyzes the worldwide markets for Bioterrorism in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, Asia, and Middle East. Annual forecasts are provided for each region for the period of 2001 through 2015. The report profiles 66 companies including many key and niche players worldwide such as Acambis Plc., AVI BioPharma, Inc., Bl? 1/4 cher Gmbh, Evogen, Inc., Human Genome Sciences Inc., ICX Technologies, Inc., ILC Dover LP, Medarex, Inc., Northrop Grumman Corporation, PharmAthene, Inc., Scott Health & Safety, Smiths Detection, The Baker Company, Universal Detection Technology and Universal Detection Technology. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Content

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1.INTRODUCTION
- Current & Future Analysis
- Market Overview
2.UNDERSTANDING BIOTERRORISM
- A Brief Historic Account on Bioterrorism
- Why Biological Agents?
- An Ideal Biological Weapon Candidate
- Bioterrorism is Easy: The Myth!
- Biological Agents/Diseases with Potential for Biological Warfare
- Properties of Biological Agents with Potential for Use as Weapons of Mass Destruction
- Anthrax
- The Anthrax History
- Types of Anthrax
- Inhalational Anthrax
- Cutaneous Anthrax
- Gastrointestinal Anthrax
- The Anthrax Symptoms, Treatment, and Vaccination
- Smallpox
- The Smallpox History
- Plague
- The Plague History
- Types of Plague
- Bubonic Plague
- Pneumonic Plague
- Botulism
- Tularemia
- The Tularemia History
- Viral Hemorrhagic Fevers
- Ebola Hemorrhagic Fever
- Marburg Hemorrhagic Fever
- Lassa Hemorrhagic Fever
- Q Fever
- Brucellosis
- Ricin
- Others
3.MODES OF DELIVERY
- Aerosol Dissemination
- Water Contamination
- Food Contamination
- Insect Vectors
- Other
4.BIOTERRORISM DEFENSE PRODUCTS AND DETECTION EQUIPMENT
- Detection Equipment
- Point Detection Systems
- Standoff Detection Systems
- Passive Standoff Detection Systems
- Defense Products
- Vaccines
- Personal Protective Equipment
5.RECENT INDUSTRY ACTIVITY
- Sanofi Pasteur Acquires Acambis
- PharmAthene Acquires Avecia Biodefense Vaccines Business
- ICx Technologies Completes S3I Acquisition
- Johnson & Johnson to Acquire Omrix
- Emergent BioSolutions Enters into Joint Venture with Ninebio Sdn Bhd
- Alert B&C, Frontline Robotics, and Dragon Securite Sign MoU
- Universal Detection and Kadinuo Sign Agreement
- PharmAthene Signs Marketing Pact with Medison for Israeli Market
- PharmAthene Forms Alliance with Panacea Biotec
- Innovative Biosensors and Universal Detection Plan Collaboration
- Acambis Wins Government Contract for ACAM2000??? Smallpox Vaccine
- Crucell, Integrated BioTherapeutics Win NIAID Funding for Vaccine Development
- Universal Detection Secures Repeat Order for Biodetection Kits
- Universal Detection Secures Repeat Order for Biodetection Training Equipment
- Universal Detection Secures and Completes Contract
- Hawaii Emergency Medical Services Orders Simulation and Bio-Detection Kits
- IR BioSciences Raises Financing for Drug Development
- AVI BioPharma Files IND for Marburg
- ICx Technologies Completes GHC Technologies Acquisition
- NanoSensors to Acquire DKL International
- Allen-Vanguard to Acquire Hazard Management Solutions
- PharmAthene Announces Reverse Merger to Acquire Healthcare Acquisition
- CytoGenix Enters into CRADA with USAMRIID
- Advanced Life Sciences Announces Collaboration with NIAID
- U.S. BioDefense to Receive Exclusive License from Shine Holdings
- Emergent BioSolutions Signs Agreement to License VaxImmune
- Universal Detection Signs Distribution Agreement with ADVNT
- Universal Detection Secures Gulf Security Order for Detection Kits
- Dycor Technologies Wins Rheinmetall Landsystems Contract
- AVI BioPharma Secures Bioterrorism Response Therapies Contracts
- Emergent BioSolutions Wins HHS Anthrax Biodefense Contract
- Nanotherapeutics Wins Anti-Bioterrorism Drug Contract from NIAID/ BARDA
- SRI International Secures Contract for Anti-Biological Threat Drugs from DTRA
- Universal Detection Completes Foot Locker Order for Bioterrorism Detection Kits
- PharmAthene Wins HHS Biodefense Contract
- Ibis Biosciences Receives Four New Contracts from Government
- Universal Detection Receives Guaranteed Order from SSI
- Ichor Receives Navy Contract for Vaccine Development
- PharmAthene Receives Contract to Develop Anthrax Anti-Toxin
- General Dynamics Canada Secures Contract from Canadian Forces
- Universal Detection Commences R&D for Portable Anthrax Detector
- BioFactura Completes Initial Clinical Testing
6.PRODUCT LAUNCHES
- Smiths Detection Introduces SmartBio??? Biological Agents Detector
- Safe Life Launches Triosyn Disposable Respirators
- ICx Unveils Integrated System for CBR Threat Detection, SafeAir???
- Innovative Biosensors Unveils BioFlash Biological Detector
- Lawrence Laboratory Develops Biological, Chemical Agent Detection Machine
7.FOCUS ON SELECT PLAYERS
- Acambis Plc (UK)
- AVI BioPharma, Inc. (USA)
- Bl? 1/4 cher Gmbh (Germany)
- Evogen, Inc. (USA)
- Human Genome Sciences Inc. (USA)
- ICX Technologies, Inc. (USA)
- ILC Dover LP (USA)
- Medarex, Inc. (USA)
- Northrop Grumman Corporation (USA)
- PharmAthene, Inc. (USA)
- Scott Health & Safety (USA)
- Smiths Detection (USA)
- The Baker Company (USA)
- Universal Detection Technology (USA)
8.GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment by Geographic Region ??